New Patient Interview

Watch an interview of a Japanese cornea blind patient that achieved 20/20 vision with the KeraKlear artificial cornea. The patient underwent KeraKlear surgery by Kazuo Tsubota, MD, Chairman of Ophthalmology at Keio University, Tokyo, Japan.

The KeraKlear is indicated for patients that have non-inflammatory forms of corneal blindness (e.g. keratoconus, corneal dystrophies, corneal scars, and corneal edema). The KeraKlear should not be used in patients with inflammatory causes of corneal blindness such as Steven’s Johnson Syndrome, ocular cicatricial pemphigoid or atopic keratoconjunctivitis.